risedronic acid has been researched along with zonisamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hosoda, N; Ishii, M; Iwasaki, T; Nakamura, S; Takei, K; Yokota, Y | 1 |
1 review(s) available for risedronic acid and zonisamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for risedronic acid and zonisamide
| Article | Year |
|---|---|
Secondary osteoporosis in long-term bedridden patients with cerebral palsy.
Topics: Absorptiometry, Photon; Adolescent; Alkaline Phosphatase; Anticonvulsants; Benzodiazepines; Biomarkers; Bone Density; Bone Density Conservation Agents; Cerebral Palsy; Child; Child, Preschool; Clobazam; Collagen Type I; Double-Blind Method; Drug Therapy, Combination; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Infant; Isoxazoles; Lumbar Vertebrae; Male; Osteoporosis; Peptides; Retrospective Studies; Risedronic Acid; Severity of Illness Index; Time Factors; Treatment Outcome; Zonisamide | 2008 |